Your browser doesn't support javascript.
loading
Exposure-Response Model With Time-Varying Predictors to Estimate the Effects of Veliparib in Combination With Carboplatin/Paclitaxel and as Monotherapy: Veliparib Phase 3 Study in BRCA-Mutated Advanced Breast Cancer (BROCADE3) Trial.
Stodtmann, Sven; Eckert, Doerthe; Joshi, Rujuta; Nuthalapati, Silpa; Ratajczak, Christine K; Menon, Rajeev; Mensing, Sven; Xiong, Hao.
Afiliação
  • Stodtmann S; AbbVie Deutschland GmbH Co. KG, Clinical Pharmacology and Pharmacometrics Ludwigshafen, Ludwigshafen, Germany.
  • Eckert D; AbbVie Deutschland GmbH Co. KG, Clinical Pharmacology and Pharmacometrics Ludwigshafen, Ludwigshafen, Germany.
  • Joshi R; AbbVie Inc., Clinical Pharmacology and Pharmacometrics, North Chicago, Illinois, USA.
  • Nuthalapati S; AbbVie Inc., Clinical Pharmacology and Pharmacometrics, North Chicago, Illinois, USA.
  • Ratajczak CK; AbbVie Inc., Oncology Development, North Chicago, Illinois, USA.
  • Menon R; AbbVie Inc., Clinical Pharmacology and Pharmacometrics, North Chicago, Illinois, USA.
  • Mensing S; AbbVie Deutschland GmbH Co. KG, Clinical Pharmacology and Pharmacometrics Ludwigshafen, Ludwigshafen, Germany.
  • Xiong H; AbbVie Inc., Clinical Pharmacology and Pharmacometrics, North Chicago, Illinois, USA.
J Clin Pharmacol ; 62(10): 1236-1246, 2022 10.
Article em En | MEDLINE | ID: mdl-35403245
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Benzimidazóis / Neoplasias da Mama / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Benzimidazóis / Neoplasias da Mama / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article